Epigenomics AG / Key word(s): Regulatory Admission 08.01.2016 07:55 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act) Epigenomics […]
Category: Insider Information
08. January 2016
Epigenomics receives FDA notification about status of pending approval decision for Epi proColon(R)
Read more
25. November 2015
Epigenomics AG appeals recent FDA request for additional information
Epigenomics AG / Key word(s): Miscellaneous 25.11.2015 22:41 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act) Epigenomics AG […]
04. November 2015
Epigenomics AG: Epigenomics adjusts 2015 outlook after FDA response letter
Epigenomics AG / Key word(s): Miscellaneous 04.11.2015 20:30 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Epigenomics adjusts 2015 outlook after FDA response letter Berlin, Germany, November 4, 2015 – […]
04. November 2015
Epigenomics AG: FDA requests further data for approval of Epigenomics’ blood-based colorectal cancer screening test
Epigenomics AG / Key word(s): Regulatory Admission 04.11.2015 20:19 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— FDA requests further data for approval of Epigenomics’ blood-based colorectal cancer screening test […]
28. May 2015
Epigenomics AG: Epigenomics AG Places Maximum Number of New Shares in Capital Increase with Pre-emptive Rights
Epigenomics AG / Key word(s): Capital Increase 28.05.2015 11:25 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act) Epigenomics […]
11. May 2015
Ad Hoc Announcement pursuant to Sec. 15 WpHG (German Securities Trading Act): Epigenomics AG Announces Capital Increase up to EUR 5M
Epigenomics AG / Key word(s): Capital Increase/Miscellaneous 11.05.2015 08:38 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Not for distribution in the United States of America Berlin, Germany, May 11, […]